Page 1

Studies in voorbereiding – Afdeling Hematologie

Externe code




A prospective non-interventional post-authorization safety study CC-5013-MDS010

(PASS), designed as a disease registry of patients with transfusion

Langemeijer, S.M.C.


Stevens, W.B.C.


Spronsen, van D.J.


Croockewit, A.J.


Schaap, N.P.M.


Schaap, N.P.M.


Blijlevens, N.M.A.


Evers, D.


Laros, B.A.P.


dependent IPSS low or intermediate-1-risk myelodysplastic syndromes (MDS) and isolated del(5q) Phase I-II study combining brentuximab vedotin with second line salvage chemotherapy (R-DHAP) in CD30 positive diffuse large


B-cell lymphoma patients refractory to first line chemotherapy or in first relapse who are eligible for high dose treatment followed by autologous stem cell transplantation

Biobank B-cel

Pathogenese en therapie respons van B-cel maligniteiten



A phase 2 study of nivolumab combined with daratumumab with or without low-dose cyclophosphamide in relapsed/refractory multiple myeloma An international multi-centric observational study on the use of


ruxolitinib in the treatment of patients with polycythemia vera resistant or intolerant to hydroxyurea


Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) A first-in-patient, multi-center, double-blind, placebo controlled, ascending dose, randomized phase 1B/2A study, investigating the safety, tolerability, pharmacokinetics and


pharmacodynamics of subcutaneous administration of the GLP2 receptor agonist FE 203799 in adults with lymphomas, undergoing myeloablative conditioning chemotherapy followed by autologous hematopoietic stem cell transplantation The BITE study: a nationwide epidemiological and laboratory


case cohort study investigating risk factors for bleeding in hemato-oncology patients


Shared medical appointments to change lifestyles of overweight hemophilia patients

Studies in voorbereiding – Afdeling Hematologie – Radboudumc Juni 2018


Obizur EU

Prospective, non-interventional study to evaluate the safety and


effectiveness of Obizur in real-life practice



The Dynamic interplay between bleeding phenotype and baseline factor level in moderate and mild hemophilia A and B Haemophilia in the Netherlands 6

Schols, S.E.M.


Brons, P.P.T.


Schols, S.E.M.

07 - 2018

Indien u nadere informatie wenst over een studie van afdeling Hematologie, dan kunt u contact opnemen met het Trialbureau Hematologie, bereikbaar via telefoonnummer 024 – 3614794 en/of e-mail

Studies in voorbereiding – Afdeling Hematologie – Radboudumc Juni 2018


Hemat studies in voorbereiding 03 2017  
Hemat studies in voorbereiding 03 2017